CN101879197A - Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof - Google Patents
Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof Download PDFInfo
- Publication number
- CN101879197A CN101879197A CN 201010144871 CN201010144871A CN101879197A CN 101879197 A CN101879197 A CN 101879197A CN 201010144871 CN201010144871 CN 201010144871 CN 201010144871 A CN201010144871 A CN 201010144871A CN 101879197 A CN101879197 A CN 101879197A
- Authority
- CN
- China
- Prior art keywords
- turpinia
- extractive
- reflux
- leaf ethanol
- turpinia montana
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a turpinia montana leaf ethanol reflux extractive which is obtained by extracting turpinia montana and ethanol. The specific extract method is as follows: getting turpinia Montana leaves, adding 30-90% of ethanol with the volume of 5-15 times of the volume of the turpinia Montana leaves, carrying out reflux extraction for 1-3 times, and filtering, wherein the time of each reflux extraction is 1-3 hours; and combining the filter liquors, decompressing and concentrating the combine filter liquor into a thick paste, and drying to obtain the turpinia montana leaf ethanol reflux extractive. The extractive can serve as a neuraminidase inhibitor to be used for preventing and curing influenza, and can be prepared into a pharmaceutically acceptable dosage form.
Description
Technical field
The present invention relates to a kind of turpinia Montana leaf ethanol reflux extractive and its production and use.
Background technology
Influenza virus is serious day by day at present, and influenza virus and respiratory tract disease and the systemic disease that causes are closely related, China is one of influenza country occurred frequently, not only populous, and living habit also helps the relay of influenza virus, the number of times of falling ill for each person every year reaches 0.3～0.7 time not to be waited, and key population reaches 2～4 times.There is serious threat in influenza to the mankind, New Development kind influenza virus especially, and it not only causes other infected by microbes of Secondary cases, and can directly cause organ to destroy and the allergy causing death.But effectively do not treat the method and the treatment means of influenza virus and disease (influenza) thereof at present,, cure the symptoms, not the disease as carry out the inflammatory reaction treatment at clinical symptoms.The method of present modal prevention and treatment influenza virus is to use influenza virus vaccine inoculation, non-specific anti virus herb or Western medicine oseltamivir phosphate (oseltamivir phosphate capsule)-neuraminidase inhibitor.Yet influenza virus vaccine prophylactic immunization drawback is that the inoculation crowd is selective, is not that everybody can inoculate.In addition, the influenza virus vaccine protective rate is not high, and guard time is also lacked (3～6 months).Though most of non-specific anti virus herbs lay claim to antivirus action at present, be not at influenza virus, and antivirus action mechanism are unclear.At many kind treatment affection of exogenous wind-cold of our former studies, the Chinese prescription of the flu that doctor trained in Western medicine is thought does not have the effect of direct resisiting influenza virus.Briefly, the Chinese prescription of not every treatment flu all has the effect of clear and definite inhibition influenza virus.Western medicine " oseltamivir phosphate (oseltamivir phosphate capsule; (3R; 4R; 5S)-4-acetamide-5-amino-3 (1-third 2-ethoxyethyl acetate)-1-cyclohexene-1 carboxylic acid, ethyl ester phosphate) " be neuraminidase inhibitor, influenza virus is entered cell specific inhibitory effect is arranged, but not only cost an arm and a leg, and have that some patients take that the back vomiting occurs, feels sick, side reactions such as insomnia, headache, stomachache, diarrhoea, dizziness, fatigue, nasal obstruction, pharyngalgia and cough.Oseltamivir phosphate capsule is that the esterase that is positioned at liver and intestinal in vivo is converted into active metabolite and plays the neuraminidase effect that suppresses, and also will influence its drug effect if patient's liver and intestinal organ dysfunction are undesired.In addition, the renal insufficiency patient also wants careful usefulness.
Therefore, specific aim suppresses influenza virus and duplicates, suppresses influenza neuraminidase hydrolysis cell surface sialic acid, thereby cause influenza virus not combine and to enter in the cell, and the minimizing influenza virus will be the cause of disease that treatment influenza virus sexuality is emitted in intracellular generation with cell surface receptor.
Summary of the invention
The purpose of this invention is to provide a kind of turpinia Montana leaf ethanol reflux extractive, suppress influenza neuraminidase hydrolysis cell surface sialic acid, cause influenza virus not combine and to enter in the cell with cell surface receptor, duplicating thereby can effectively suppress influenza virus, more importantly is the side reaction drawback that overcomes medicine.
Another object of the present invention has provided a kind of preparation method of turpinia Montana leaf ethanol reflux extractive.
Another object of the present invention has provided the purposes of the medicine of turpinia Montana leaf ethanol reflux extractive preparation prevention and treatment influenza and complication disease thereof;
Another object of the present invention has provided the pharmaceutical composition that contains turpinia Montana leaf ethanol reflux extractive.
Turpinia Montana leaf ethanol reflux extractive of the present invention, it obtains by Turpinia pomifera(Roxb) D O. is added ethanol extraction, and concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 30%～90% alcohol reflux 1～3 time of 5～15 times of volumes, each reflux, extract, 1～3 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Preferably, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 40%～85% alcohol reflux 2～3 times of 5～13 times of volumes, each reflux, extract, 1～2.5 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Preferred, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 50%～80% alcohol reflux 2～3 times of 5～11 times of volumes, each reflux, extract, 1～2 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Preferred, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 55%～75% alcohol reflux 2～3 times of 5～10 times of volumes, each reflux, extract, 1～1.5 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Preferred, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., at every turn with 60～75% ethanol of 6～9 times of volumes as extracting solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid,, filter, be evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Preferably, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., at every turn with 65% ethanol of 7 times of volumes as extracting solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid, filtered, and was evaporated to thick paste or dry turpinia Montana leaf ethanol reflux extractive.
Preferred, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., at every turn with 70% ethanol of 8 times of volumes as extracting solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid,, filter, be evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
The purposes that the present invention also provides turpinia Montana leaf ethanol reflux extractive to be used to prepare prevention and to treat the medicine of influenza and complication disease thereof.
Preferably, turpinia Montana leaf ethanol reflux extractive is used to suppress influenza virus.
Preferably, turpinia Montana leaf ethanol reflux extractive is used to suppress influenza virus FM1.
Preferably, turpinia Montana leaf ethanol reflux extractive is used to suppress neuraminidase.
Preferably, its complication is meant renal failure.
Preferably, its complication is meant splenic trauma or/and injury of lung.
The present invention also provides a kind of turpinia Montana leaf ethanol reflux extractive preparation, and said preparation is main active with the turpinia Montana leaf ethanol reflux extractive.
Turpinia Montana leaf ethanol reflux extractive of the present invention can extract effective inhibition neuraminic acid enzyme component, turpinia Montana leaf ethanol reflux extractive is along with the using dosage size variation, it suppresses the active ability of neuraminidase, be also corresponding the changing of height of neuraminic acid enzyme inhibition rate, and one-tenth positive correlation, turpinia Montana leaf ethanol reflux extractive can be by suppressing influenza virus surface neuraminidase, and then the inhibition influenza virus enters the cell the inside, inhibition has entered the influenza virus of cell the inside and has duplicated, propagation, thereby reduced the infection of influenza virus pair cell, growth, and prevention and treatment influenza and complication thereof.
The specific embodiment
Turpinia Montana leaf ethanol reflux extractive of the present invention, it obtains by Turpinia pomifera(Roxb) D O. is added ethanol extraction, and concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 5～15 times of amount 30%～90% alcohol reflux 1～3 time, each reflux, extract, 1～3 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 1
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 13 times of amount 45% alcohol reflux 3 times, each reflux, extract, 2.5 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 2
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 11 times of amount 50% alcohol reflux 3 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 3
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 12 times of amount 70% alcohol reflux 3 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 4
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 9 times of amount 65% alcohol reflux 3 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 5
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 8 times of amount 70% alcohol reflux 2 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 6
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 7 times of amount 65% alcohol reflux 2 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 7
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 9 times of amount 68% alcohol reflux 2 times, each reflux, extract, 2 hours filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Embodiment 8
Preparation method: get leaf of Turpinia pomifera (Roxb) D O., add 5 times of amount 85% alcohol reflux 1 time, reflux, extract, 1 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
Experimental data 1, extraction process optimization research
Leaf of Turpinia pomifera (Roxb) D O. mainly contains chemical compounds such as flavonoid, organic acid, flavone compound is preferable with the ethanol extraction effect, therefore, we with concentration of alcohol (A), add four of amount of alcohol (B), extraction time (C), extraction time (D) as the investigation factor, each factor is established three levels, presses L9 (3
4) orthogonal table carries out orthogonal experiment design (table 1, table 2) extraction process is optimized research, investigating index is the total flavones extraction ratio.
Table 1 factor level table
Get 27 parts of leaf of Turpinia pomifera (Roxb) D O. medical materials, every group average three parts, totally nine groups, by table 1L9 (3
4) the orthogonal test table design experiment.The results are shown in Table 2.
Table 2L9 (3
4) orthogonal test table
Variance analysis
Orthogonal experiments is carried out variance analysis, the results are shown in Table 3.
Table 3 is the variance analysis of index with the total flavones extraction ratio
＊F
1-0.05(2，2)＝19.0
＊＊F
1-0.01(2，2)＝99.0
Conclusion: intuitive analysis as can be known, extraction time (C) and to add amount of alcohol (B) bigger to extraction effect influence, concentration of alcohol (A) and extraction time (D) are less to the extraction effect influence.Table 3 The results of analysis of variance has further been verified the intuitive analysis conclusion, and promptly factor C, B have considerable influence to extraction effect successively.According to producing practical situation, analyze in conjunction with the K value, determine that extraction conditions is: get leaf of Turpinia pomifera (Roxb) D O., add 10 times of amount 70% ethanol and carry 3 times, extracted 2 hours, promptly at every turn.
Experimental data 2: turpinia Montana leaf ethanol reflux extractive is to the active inhibitory action of neuraminidase
Get the turpinia Montana leaf ethanol reflux extractive that embodiment 4 preparation methoies are obtained, add suitable quantity of water and make dissolving, use tiring of neuraminidase inhibitor identification kit mensuration turpinia Montana leaf ethanol reflux extractive inhibition neuraminidase (N1) and see Table 4.
(1). standard curve is prepared: a. every hole in 96 hole luciferase targets adds 70 μ l neuraminidases and detects buffer; B. every hole adds 0,1,2,5,7.5,10 μ l H5N1 neuraminidases more respectively; C. every hole adds 0～20 μ l Milli-Q water again.
(2). the preparation of sample detection: a. every hole in 96 hole luciferase targets adds 70 μ l neuraminidases and detects buffer; B. every hole adds 10 μ l H5N1 neuraminidases again; C. every hole adds 0～10 μ l turpinia Montana leaf ethanol reflux extractive sample again; D. every hole adds 0～10 μ l Milli-Q water again.
(3). detect step:
A. vibrate the about 1min of mixing;
B.37 ℃ hatch 2min inhibitor and H5N1 neuraminidase are fully interacted, the sample of doing standard curve is also hatched together;
C. every hole adds 10 μ l neuraminidase fluorogenic substrates;
D. vibrate the about 1min of mixing again;
E.37 carry out fluoremetry after ℃ hatching 20～30min.Excitation wavelength is 360nm, and emission wavelength is 440nm.
(4). calculate the inhibition percentage ratio of sample according to standard curve, and calculate the IC50 of turpinia Montana leaf ethanol reflux extractive after doing concentration curve for the H5N1 neuraminidase for the H5N1 neuraminidase.The suppression ratio IC50 that turpinia Montana leaf ethanol reflux extractive reaches neuraminidase is 9.97mg/ml.See Table 4.
Table 4. turpinia Montana leaf ethanol reflux extractive suppresses the activity of neuraminidase
Can be clear that according to above-mentioned experimental result:
(1). turpinia Montana leaf ethanol reflux extractive can extract effective inhibition neuraminic acid enzyme component;
(2). turpinia Montana leaf ethanol reflux extractive is along with the using dosage size variation, and it suppresses the active ability of neuraminidase, and promptly the height of neuraminic acid enzyme inhibition rate is also corresponding changes, and becomes positive correlation;
(3). by above-mentioned experiment as seen, turpinia Montana leaf ethanol reflux extractive can be by suppressing influenza virus surface neuraminidase, and then suppress that influenza virus enters the cell the inside, the influenza virus that suppresses to have entered the cell the inside duplicates, breeds, thereby reduced infection, the growth of influenza virus pair cell, and prevention and treatment influenza and complication thereof.
Medical science and study of pharmacy personnel can't not do the inhibition influenza infection, duplicate in advance, or under the prerequisite of the experiment of inhibition neuraminidase, learn that in advance turpinia Montana leaf ethanol reflux extractive has prevention and treats the good result that the influenza virus sexuality is emitted.
Experimental data 3: turpinia Montana leaf ethanol reflux extractive infects the inhibitory action of Embryo Gallus domesticus to influenza virus
Get turpinia Montana leaf ethanol reflux extractive, add suitable quantity of water and make dissolving, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify that turpinia Montana leaf ethanol reflux extractive suppresses the ability that the FM1 influenza virus is duplicated and suppresses in Embryo Gallus domesticus.(1). FM1 influenza virus liquid is inoculated in no-special pathogen chick embryo allantois intracavity in 10 day age, and every embryo 0.2ml was hatched 72 hours for 37 ℃, observed and calculate half Embryo Gallus domesticus infective dose (EID50).(2). turpinia Montana leaf ethanol reflux extractive adopts the toxic action of Embryo Gallus domesticus, physiological saline solution is done to be inoculated in no-special pathogen chick embryo allantois intracavity in 10 day age behind the serial dilution to turpinia Montana leaf ethanol reflux extractive, every embryo 0.2ml, each concentration is inoculated 6 embryos, hatch for 37 ℃, observe Embryo Gallus domesticus growth promoter situation, the Cmax that can survive 96 hours with Embryo Gallus domesticus is as the TD of medicine.(3). turpinia Montana leaf ethanol reflux extractive inhibitory action to influenza virus in Embryo Gallus domesticus adopts, 0.1ml influenza virus liquid and different dilution turpinia Montana leaf ethanol reflux extractives mix, 37 ℃ act on 2 hours, be inoculated in no-special pathogen chick embryo allantoic cavity in 10 day age, every winding kind 6 embryos were hatched 72 hours for 37 ℃.The virus attack amount is 50EID50, establishes virus control, physiological saline solution normal control simultaneously, calculates the median effective dose (ED50) of turpinia Montana leaf ethanol reflux extractive to viral inhibition.
(1) the .FM1 influenza virus is calculated through the Reed-Muench method the virulence of Embryo Gallus domesticus, and its EID50 is 10
-5.07(2). after turpinia Montana leaf ethanol reflux extractive is inoculated in Embryo Gallus domesticus, its growth promoter and normal control group basically identical.Embryo Gallus domesticus was all survived in 96 hours.Embryo Gallus domesticus gives turpinia Montana leaf ethanol reflux extractive stock solution and does not see chicken embryo death, so can think that TD0 is 9.0g/100ml.(3). turpinia Montana leaf ethanol reflux extractive inhibitory action to influenza virus in Embryo Gallus domesticus sees Table 5.
Table 5. turpinia Montana leaf ethanol reflux extractive infects the inhibitory action of Embryo Gallus domesticus to influenza virus
Compare with the virus control group: * P＜0.05
As shown in Table 5, turpinia Montana leaf ethanol reflux extractive has significant inhibitory effect (P＜0.05) at 22.5～90.0mg/ml to influenza virus, and ED50 is 22.5mg ± 1.92mg/ml, and TI is 16.34 ± 1.35.
Experimental data 4: turpinia Montana leaf ethanol reflux extractive influences the FM1 influenza virus
Get turpinia Montana leaf ethanol reflux extractive, add suitable quantity of water and make dissolving, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify that turpinia Montana leaf ethanol reflux extractive suppresses the ability of FM1 influenza virus virulence.(1) .FM1 adopts cell median infective dose (TCID50) micromethod to the toxicity test of Testis et Pentis Canis passage cell (MDCK).(2). turpinia Montana leaf ethanol reflux extractive adopts the DMEM of serum-free that turpinia Montana leaf ethanol reflux extractive is done to be inoculated in the mdck cell hole that forms monolayer behind the serial dilution to the toxicity test of mdck cell, every hole 100 μ l, each dilution factor repeats 4 holes, establishes the normal cell contrast simultaneously.Culture plate is put 37 ℃, 5%CO
2Cultivate in the incubator, observation of cell pathological changes every day (CPE) was observed 3 days continuously, with " +～++ ++ " the record result, press the Reed-Muench method and calculate medicine median toxic concentration (TD50) and maximal non-toxic concentration (TD0).(3). turpinia Montana leaf ethanol reflux extractive suppresses the effect of FM1 influenza virus and measures: mdck cell 5 * 10
5/ ml, every hole 100 μ l, in 96 orifice plates, 37 ℃, 5%CO
2Cultivate in the incubator, inhale next day and remove culture fluid in the hole, add 100TCID50 influenza virus liquid, every hole 100 μ l inhale behind 37 ℃ of absorption 1h and remove supernatant.Wash 2 times with phosphate buffer (PBS), TD0 with medicine is the 1st hole, and the DMEM liquid of reuse serum-free is made serial dilution to turpinia Montana leaf ethanol reflux extractive, adds respectively in the cell of above-mentioned infective virus, establish virus control and normal control group simultaneously, 37 ℃, 5%CO
2Cultivate in the incubator, observe the mdck cell characteristics of lesion that influenza virus produces every day, i.e. cell monolayer degeneration becomes circle etc., for three days on end, calculates 50% of medicine and suppresses pathological changes concentration (IC50) and therapeutic index (TI).The calculating of TI: TI=TD50/IC50, the TI value is big more, shows that the safety range of medicine is big more.With Kruskal-Walis and Mann-Whitney method of inspection comparative test group and the cytopathic difference of virus control group, drug dose and suppression ratio that virus infected cell is avoided cytopathy (CPE) takes place are carried out correlation analysis, judge whether amount validity response relation.
(1) the .FM1 influenza virus is calculated through the Reed-Muench method the virulence of mdck cell, and its TCID50 is 10
-481(2). the TD0 of turpinia Montana leaf ethanol reflux extractive mdck cell is respectively 1026.4mg ± 30.27mg/100ml.(3). after turpinia Montana leaf ethanol reflux extractive made serial dilution, the 100TCID50 influenza virus is carried out inhibition test, median effective dose IC50 and the TI value of calculating medicine are big or small, the results are shown in Table 6.
Table 6. turpinia Montana leaf ethanol reflux extractive is to the IC50 (mg/100ml) of FM1 influenza virus and TI (x ± s)
As shown in Table 6, the cytopathogenic effect of turpinia Montana leaf ethanol reflux extractive inhibition FM1 influenza virus all strengthens along with the increase of drug dose.Drug dose and medicine are shown that to the correlation analysis that the suppression ratio of CPE carries out the dosage of turpinia Montana leaf ethanol reflux extractive and medicine are to being tangible positive correlation between the CPE suppression ratio.
Experimental data 5: turpinia Montana leaf ethanol reflux extractive is to the death protection result of influenza virus infection FM1 strain in the mice body
Get turpinia Montana leaf ethanol reflux extractive, use influenza virus A-prime Mus lung adapted strain (FM1) and (H1N1) identify the dead protective effect of turpinia Montana leaf ethanol reflux extractive influenza virus infection FM1 strain in the mice body.(1). influenza virus FM1 strain virus is inoculated every group of 10 BALB/C mice respectively, male and female half and half after doing 10 times of doubling dilutions.After the slight anesthesia of ether, give and different dilution viruses respectively for every group, every mice collunarium is inoculated 20 μ l.Observe 10 days dead mouse situation, calculating LD50 by the Reed-Muench method is 10-
1.36So determine that the used modeling concentration of experiment is 10LD50.(2). turpinia Montana leaf ethanol reflux extractive is to the dead protective effect of influenza virus infection FM1 strain in the mice body: normal control group, influenza virus FM1 strain virus matched group, turpinia Montana leaf ethanol reflux extractive 11.25mg/ml, 22.5mg/ml, 45.0mg/ml, 90.0mg/ml dosage group etc. are irritated stomach respectively, irritate gastric capacity and only are 0.4ml/.After 3 days, each group is only used 10LD50 influenza virus FM1 strain collunarium infecting mouse 20 μ l/ under the slight anesthesia of ether except that the normal control group.The normal control group gives the normal saline with volume simultaneously.4 groups of administration are continued administration, normal control group and influenza virus FM1 strain virus control group administered physiological saline 8 days, and dosage is the same.Day by day observe animal morbidity and record death toll, observed altogether 14 days, calculate mortality rate (mortality rate=every group of death toll/every group of total mice * 100%), the results are shown in Table 7.(3). turpinia Montana leaf ethanol reflux extractive is to the exponential influence of influenza virus infection FM1 strain lung in the mice body: normal control group, influenza virus FM1 strain virus matched group, turpinia Montana leaf ethanol reflux extractive 11.25mg/ml, 22.5mg/ml, 45.0mg/ml, 90.0mg/ml dosage group etc. are irritated stomach respectively, irritate gastric capacity and only are 0.4ml/.After 3 days, each group is only used 1.0LD50 influenza virus FM1 strain collunarium infecting mouse 20 μ l/ under the slight anesthesia of ether except that the normal control group.The normal control group gives the normal saline with volume simultaneously.4 groups of administration are continued administration, normal control group and influenza virus FM1 strain virus control group administered physiological saline 8 days, and dosage is the same.Behind viral infection, put to death mice on the 8th day, weigh, get lung and claim lung heavy, calculate lung index (lung index=lung quality/body constitution amount * 100%); In addition, get spleen and claim spleen heavy, calculate spleen index (spleen index=spleen quality/body constitution amount * 100%), the results are shown in Table 7.
Table 7. turpinia Montana leaf ethanol reflux extractive is to the death protection result of influenza virus infection FM1 strain in the mice body
Annotate: ※ ※ P＜0.01VS influenza virus model group
Table 8. turpinia Montana leaf ethanol reflux extractive is to the spleen index and the exponential influence of lung of influenza virus infection FM1 strain in the mice body
Annotate: ##P＜0.01VS normal control group ※ p＜0.05VS influenza virus model group
(1). as shown in Table 7, turpinia Montana leaf ethanol reflux extractive has significant protective effect (p＜0.01) at 45.0～90.0mg/ml to the influenza virus infecting mouse.
(2). as shown in Table 8, turpinia Montana leaf ethanol reflux extractive has significant effect (p＜0.05) at 90.0mg/ml to the lung index suppression ratio of influenza virus infecting mouse.
Experimental data 6: turpinia Montana leaf ethanol reflux extractive is to the influence of chronic renal failure
1) SD rat, 200～240g, Shanghai west pul-Bi Kai laboratory animal responsibility company limited, the animal quality certification number: SCXK (Shanghai) 2003-0002
2) reagent and medicine adenine, adenine (content＞98% is the import packing, Chinese Shanghai, lot number 20010520), the turpinia Montana leaf ethanol reflux extractive that embodiment 4 preparation methoies are obtained;
3) test method: male SD rat, about body weight 220g, earlier feed 10 days normal growths with normal diet after, be divided into normal control group, administration experimental group and modeling matched group at random by body weight, 12 every group.Administration experimental group and modeling matched group are irritated stomach with adenine and are made chronic renal failure (CRF) model, irritate stomach with adenine 320mg/ (kgd), only make the about 2ml/ of suspension with distilled water, totally 20 days; Administration after 20 days, the administration experimental group is irritated stomach with turpinia Montana leaf ethanol reflux extractive 1.2g/ (kgd), turpinia Montana leaf ethanol reflux extractive is made suspension solution (0.2g/ml) with distilled water, each about 2ml/ only, stomach is irritated in gradation, normal control group and modeling matched group are irritated stomach with equal-volume water, and administration was used etherization with rat after 35 days. and every index is observed in the blood sampling of Mus arteria caudalis.
4) result:
Table 9. turpinia Montana leaf ethanol reflux extractive is to the influence of CRF kidney of rats function
Annotate: through the T check, administration experimental group and modeling matched group be " * " expression P＜0.05 relatively, and " * * " represents P＜0.01
This experiment is looked sidelong at purine with gland and is irritated after stomach sets up rat CRF model, modeling control rats lethargy, body weight obviously reduces, serum Bun, Ser obviously raise, Hb obviously descends, Ret obviously raises, show the rat impaired renal function, after giving the turpinia Montana leaf ethanol reflux extractive treatment. rat spirit is obviously bestirred oneself, and body weight is recovered gradually, improves creatinine clearance rate, promote the discharge of metabolite, reduce serum BUN, SCr concentration, renal function and anemia are obviously improved, and show that turpinia Montana leaf ethanol reflux extractive has preventive and therapeutic effect to kidney of rats damage due to the adenine.
Can be clear that according to above-mentioned experimental result:
(1). turpinia Montana leaf ethanol reflux extractive can extract effectively preventing chronic renal failure composition;
(2). turpinia Montana leaf ethanol reflux extractive suppresses the active effect of neuraminidase simultaneously having, also have the effect of the chronic renal failure controlled, and has overcome oseltamivir phosphate capsule sternly to clear ability of creatinine and renal failure crowd's side effect, on the contrary prevention effect in addition.
Claims (14)
1. turpinia Montana leaf ethanol reflux extractive, it obtains by leaf of Turpinia pomifera (Roxb) D O. is added ethanol extraction, and concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 30%～90% alcohol reflux 1～3 time of 5～15 times of volumes, each reflux, extract, 1～3 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
2. turpinia Montana leaf ethanol reflux extractive as claimed in claim 1, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 40%～85% alcohol reflux 2～3 times of 5～13 times of volumes, each reflux, extract, 1～2.5 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
3. turpinia Montana leaf ethanol reflux extractive as claimed in claim 2, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 50%～80% alcohol reflux 2～3 times of 5～11 times of volumes, each reflux, extract, 1～2 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
4. turpinia Montana leaf ethanol reflux extractive as claimed in claim 3, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., add 55%～75% alcohol reflux 2～3 times of 5～10 times of volumes, each reflux, extract, 1～1.5 hour filters; Merging filtrate is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
5. turpinia Montana leaf ethanol reflux extractive as claimed in claim 4, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., each 60～75% ethanol with 6～9 times of volumes are as the extraction solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid, filters, and is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
6. turpinia Montana leaf ethanol reflux extractive as claimed in claim 5, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., each 65% ethanol with 7 times of volumes is as the extraction solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid, filters, and is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
7. turpinia Montana leaf ethanol reflux extractive as claimed in claim 5, concrete extracting method is as follows: get leaf of Turpinia pomifera (Roxb) D O., each 70% ethanol with 8 times of volumes is as the extraction solvent, reflux, extract, 2 times, each 2 hours, merge extractive liquid, filters, and is evaporated to thick paste or the dry turpinia Montana leaf ethanol reflux extractive that gets.
8. each described turpinia Montana leaf ethanol reflux extractive of claim 1～7 is used to prepare the purposes of preventing and treating the medicine of influenza and complication disease thereof.
9. purposes as claimed in claim 8 is characterized in that suppressing influenza virus.
10. purposes as claimed in claim 8 is characterized in that suppressing influenza virus FM1.
11. purposes as claimed in claim 8 is characterized in that suppressing neuraminidase.
12. purposes as claimed in claim 8, its complication is meant renal failure.
13. purposes as claimed in claim 8, its complication is meant splenic trauma or/and injury of lung.
14. a turpinia Montana leaf ethanol reflux extractive preparation is characterized in that, it is main active that said preparation comprises each described turpinia Montana leaf ethanol reflux extractive of claim 1～7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101448712A CN101879197B (en) | 2010-04-13 | 2010-04-13 | Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101448712A CN101879197B (en) | 2010-04-13 | 2010-04-13 | Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103330226A Division CN102772453A (en) | 2010-04-13 | 2010-04-13 | Turpinia formosana Nakai leaf ethanol backflow extract and preparation method and applications thereof |
| CN2011103329924A Division CN102784177A (en) | 2010-04-13 | 2010-04-13 | Turpinia montana leaf ethanol reflux extractive, preparation method and application thereof |
| CN2011103330230A Division CN102920752A (en) | 2010-04-13 | 2010-04-13 | Turpinia arguta leaf ethanol reflux extract, preparation method and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101879197A true CN101879197A (en) | 2010-11-10 |
| CN101879197B CN101879197B (en) | 2012-05-23 |
Family
ID=43051426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101448712A Active CN101879197B (en) | 2010-04-13 | 2010-04-13 | Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101879197B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112263519A (en) * | 2020-10-26 | 2021-01-26 | 江西省农业科学院农产品质量安全与标准研究所 | Application of turpinia arguta plant and extract thereof in mosquito repellent product, extraction method of turpinia arguta extract and mosquito repellent product |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1680355A (en) * | 2005-01-20 | 2005-10-12 | 安徽科创中药天然药物研究所有限责任公司 | Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis |
| CN101011435A (en) * | 2007-02-25 | 2007-08-08 | 胡军 | Shanxiangyuan leaf extract, preparation method and uses thereof |
-
2010
- 2010-04-13 CN CN2010101448712A patent/CN101879197B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1680355A (en) * | 2005-01-20 | 2005-10-12 | 安徽科创中药天然药物研究所有限责任公司 | Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis |
| CN101011435A (en) * | 2007-02-25 | 2007-08-08 | 胡军 | Shanxiangyuan leaf extract, preparation method and uses thereof |
| CN101249118A (en) * | 2007-02-25 | 2008-08-27 | 胡军 | Chinese medicine extract and medicine use thereof |
Non-Patent Citations (3)
| Title |
|---|
| 《中国中药杂志》 19860825 杨义方等 山香圆不同工艺产品的抗菌作用研究 第11卷, 第08期 2 * |
| 《中国中药杂志》 20090615 章光文等 山香圆叶中黄酮类成分研究 第34卷, 第12期 2 * |
| 《中成药》 20030425 罗宪堂等 山香圆含片的制备工艺研究 第25卷, 第04期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112263519A (en) * | 2020-10-26 | 2021-01-26 | 江西省农业科学院农产品质量安全与标准研究所 | Application of turpinia arguta plant and extract thereof in mosquito repellent product, extraction method of turpinia arguta extract and mosquito repellent product |
| CN112263519B (en) * | 2020-10-26 | 2022-10-18 | 江西省农业科学院农产品质量安全与标准研究所 | Application of turpinia arguta seem plant and extract thereof in mosquito repelling product, extraction method of turpinia arguta seem extract and mosquito repelling product |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101879197B (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3277271B1 (en) | Antiviral activity from medicinal mushrooms and their active constituents | |
| US20060171958A1 (en) | Antiviral activity from medicinal mushrooms | |
| CN101890038B (en) | Nuezhenoside-rhoifolin-hyperin composite and application in medicinal preparation thereof | |
| CN101862357B (en) | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof | |
| CN101906122B (en) | Method for extracting rhoifolin and prepared medicament application thereof | |
| CN101891785B (en) | Extraction method of hyperin and application thereof in medicament preparation | |
| CN1548056A (en) | Application of chitin, chitosan and their derivatives in preparing antiviral | |
| CN101884651B (en) | Water extract of turpinia formosana leaves and preparation method and application thereof | |
| CN102633850A (en) | Rhoifolin extraction method and usage of drug prepared by rhoifolin | |
| CN101879197B (en) | Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof | |
| CN101897715B (en) | Nuezhenoside and rhoifolin composition and use thereof in preparation of drugs | |
| CN101899078B (en) | Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament | |
| CN101862358B (en) | Acute turpinia leaf ethanol percolation extract, and preparation method and application thereof | |
| CN102935098A (en) | Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof | |
| CN102579515B (en) | Folium turpiniae ethanol percolating extract, preparation method and application thereof | |
| CN102920751A (en) | Turpinia arguta leaf total flavonoid ethanol reflux extract, preparation method and uses thereof | |
| CN101904859B (en) | Rhoifolin and hyperin composition and application of medicines prepared therefrom | |
| CN102526086A (en) | Method for extracting ligustroflavone and application of ligustroflavone to preparation of medicines | |
| CN101890037B (en) | Nuezhenoside and hyperin composition and application thereof for preparing medicine | |
| CN102784177A (en) | Turpinia montana leaf ethanol reflux extractive, preparation method and application thereof | |
| CN102772453A (en) | Turpinia formosana Nakai leaf ethanol backflow extract and preparation method and applications thereof | |
| CN102920752A (en) | Turpinia arguta leaf ethanol reflux extract, preparation method and uses thereof | |
| CN102631383A (en) | Turpinia arguta seen leaf ethanol diacolation extract, preparation method thereof and application | |
| CN102631382A (en) | Turpinia arguta seen leaf ethanol diacolation extract, preparation method thereof and application | |
| CN102784178A (en) | Turpinia montana leaf general flavone ethanol reflux extractive, preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |